A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
Clinical trial NCT04939610 · RECRUITING
Trial details
- NCT number
- NCT04939610
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2027-12-31
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.